{
  "report_rows": [
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.02 vs. cons $1.89",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Revenue (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$4.87B vs. cons $5.05B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Financial Solutions Revenue (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$2.32B vs. cons $2.39B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Adj. EPS (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide $8.00-$8.30 reaffirmed vs. cons ~$8.15",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Organic Revenue (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 1-3% reaffirmed vs. cons ~2%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 2026 Revenue Acceleration (qualitative)",
      "prediction": "UNCHANGED",
      "answer": "6-8% H2 growth reaffirmed with new CEO caveats",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 sell-side trims revenue estimates post-print; EPS maintained but revenue quality concern lingers; short covering limits downside but does not reverse it",
  "day5_confidence": "MEDIUM"
}